ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Oklahoma » Ophthalmology

Top Ophthalmology Prescribers in Oklahoma

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ANTHONY ECONOMOU D.O.

Ophthalmology

4,882

$369K

701
621 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

11%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

63%
prescriptions for brand name drugs

Avg: 63%

$76
Average prescription price

Avg: $74

MARK WEISS MD

Ophthalmology

3,945

$222K

547
498 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

58%
prescriptions for brand name drugs

Avg: 63%

$56
Average prescription price

Avg: $74

STEVEN SARKISIAN MD

Ophthalmology

3,399

$251K

631
510 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 6%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

54%
prescriptions for brand name drugs

Avg: 63%

$74
Average prescription price

Avg: $74

MARC GOLDBERG MD

Ophthalmology

3,020

$219K

792
717 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

77%
prescriptions for brand name drugs

Avg: 63%

$72
Average prescription price

Avg: $74

MAHMOUD KHAIMI M.D.

Ophthalmology

2,806

$213K

506
427 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

63%
prescriptions for brand name drugs

Avg: 63%

$76
Average prescription price

Avg: $74

DEAN SHERRY M.D.

Ophthalmology

2,775

$201K

593
536 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

62%
prescriptions for brand name drugs

Avg: 63%

$72
Average prescription price

Avg: $74

JOHN BELL M.D.

Ophthalmology

2,718

$116K

562
514 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

37%
prescriptions for brand name drugs

Avg: 63%

$43
Average prescription price

Avg: $74

JEFFREY GRISHAM MD

Ophthalmology

2,663

$206K

587
551 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

77%
prescriptions for brand name drugs

Avg: 63%

$77
Average prescription price

Avg: $74

RALPH HESTER M.D.

Ophthalmology

2,563

$225K

736
690 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

72%
prescriptions for brand name drugs

Avg: 63%

$88
Average prescription price

Avg: $74

TODD BROCKMAN M.D.

Ophthalmology

2,549

$123K

541
509 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 6%

13%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

56%
prescriptions for brand name drugs

Avg: 63%

$48
Average prescription price

Avg: $74

JAMES RONK M.D.

Ophthalmology

2,432

$183K

507
492 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

66%
prescriptions for brand name drugs

Avg: 63%

$75
Average prescription price

Avg: $74

JOHN BRYAN M.D.

Ophthalmology

2,157

$61.5K

496
471 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 6%

17%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

40%
prescriptions for brand name drugs

Avg: 63%

$29
Average prescription price

Avg: $74

CHARLES GARRETT MD

Ophthalmology

2,149

$150K

430
407 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

60%
prescriptions for brand name drugs

Avg: 63%

$70
Average prescription price

Avg: $74

JOHN ROBINSON MD

Ophthalmology

2,133

$156K

401
381 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

63%
prescriptions for brand name drugs

Avg: 63%

$73
Average prescription price

Avg: $74

ANN WARN M.D.

Ophthalmology

2,104

$162K

350
300 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

66%
prescriptions for brand name drugs

Avg: 63%

$77
Average prescription price

Avg: $74

DONALD STONE M.D.

Ophthalmology

2,046

$97.8K

370
274 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

58%
prescriptions for brand name drugs

Avg: 63%

$48
Average prescription price

Avg: $74

ROBERT PARKER MD

Ophthalmology

1,993

$158K

393
366 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 6%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

58%
prescriptions for brand name drugs

Avg: 63%

$79
Average prescription price

Avg: $74

BRUCE PETTIGROVE M.D.

Ophthalmology

1,992

$197K

429
416 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

83%
prescriptions for brand name drugs

Avg: 63%

$99
Average prescription price

Avg: $74

RYAN CONLEY DO

Ophthalmology

1,989

$156K

581
488 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

88%
prescriptions for brand name drugs

Avg: 63%

$78
Average prescription price

Avg: $74

JAMES ROGERS M.D.

Ophthalmology

1,876

$106K

376
351 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

58%
prescriptions for brand name drugs

Avg: 63%

$56
Average prescription price

Avg: $74

KEVIN CROFT M.D.

Ophthalmology

1,843

$95.2K

567
486 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 6%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

35%
prescriptions for brand name drugs

Avg: 63%

$52
Average prescription price

Avg: $74

PAMELA POLAND M.D.

Ophthalmology

1,810

$161K

304
286 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

66%
prescriptions for brand name drugs

Avg: 63%

$89
Average prescription price

Avg: $74

RHEA SIATKOWSKI M.D.

Ophthalmology

1,775

$110K

286
238 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

45%
prescriptions for brand name drugs

Avg: 63%

$62
Average prescription price

Avg: $74

ZEB BRISTER M.D.

Ophthalmology

1,766

$93K

423
383 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

67%
prescriptions for brand name drugs

Avg: 63%

$53
Average prescription price

Avg: $74

DAVID KORBER M.D.

Ophthalmology

1,758

$161K

461
435 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

23%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

70%
prescriptions for brand name drugs

Avg: 63%

$91
Average prescription price

Avg: $74

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank